Physician

Muhammad Imtiaz, M.D.

According to 2025 Medicare claims, Muhammad Imtiaz, M.D. (NPI: 1639315435) practices pulmonary disease in the Binghamton, NY market, with the plurality of this provider's patient population coming from Broome, NY. This provider's primary affiliated billing organization is SOUTHERN TIER PULMONARY & CRITICAL CARE MEDICINE LLC (NPI: 1841303070; TIN: 205020595) and primary practice location at 13790-2107. Imtiaz is affiliated with the Keystone ACO (ACO ID: A1552) and AdvantagePoint Health Alliance - Laurel Highlands, LLC (ACO ID: A4657), participating under the MSSP model.

Imtiaz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 358 traditional Medicare patients, billed 1,169 HCPCS/CPT codes, and received $111,091 in Medicare payments. The top billing code was 99291 (Critical care, first 30-74 minutes). Part D data shows 1,899 prescription claims across 412 beneficiaries totaling $1,109,636 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 422 claims. Open Payments data shows 99 records totaling $2,633. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $43,165 and ending at $111,091. Concurrently, Part D prescription costs have risen steadily, from $35,719 to $1,109,636. In contrast, DME billing represents a smaller volume and rose steadily, from $1,010 to $27,238.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$75K$149K2015 Medicare payment: $43,165 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $122,342 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $149,499 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $89,042 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $86,118 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $62,928 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $62,989 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $82,328 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $112,115 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $111,091 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015140351$43,165
20164361,046$122,342
20175291,256$149,499
2018326787$89,042
2019303924$86,118
2020295830$62,928
2021242764$62,989
2022279812$82,328
20233551,138$112,115
20243581,169$111,091

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$555K$1.1M2015 Drug cost: $35,719 (USD; Tot_Drug_Cst)2016 Drug cost: $47,044 (USD; Tot_Drug_Cst)2017 Drug cost: $272,762 (USD; Tot_Drug_Cst)2018 Drug cost: $282,425 (USD; Tot_Drug_Cst)2019 Drug cost: $153,006 (USD; Tot_Drug_Cst)2020 Drug cost: $197,126 (USD; Tot_Drug_Cst)2021 Drug cost: $180,340 (USD; Tot_Drug_Cst)2022 Drug cost: $543,876 (USD; Tot_Drug_Cst)2023 Drug cost: $819,088 (USD; Tot_Drug_Cst)2024 Drug cost: $1,109,636 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153283$35,719
201669221$47,044
2017119515$272,762
201882342$282,425
2019140376$153,006
202099356$197,126
2021155475$180,340
20222861,114$543,876
20233671,558$819,088
20244121,899$1,109,636

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$34K$68K2017 Medicare payment: $2,343 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $16,514 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $4,070 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $4,800 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $22,859 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $67,571 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $50,332 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $26,965 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/R62$2,343
2018N/R148$16,514
2019N/R96$4,070
2020N/R118$4,800
202113149$22,859
202232423$67,571
202338478$50,332
202436422$26,965

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99291Critical care, first 30-74 minutes75212$159
99223Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes6870$130
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more4758$128
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more118139$91
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes90187$89

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Trelegy ElliptaFluticasone/Umeclidin/Vilanter44722,380$460,511
Fasenra PenBenralizumab241,064$141,046
Dupixent PenDupilumab35952$126,586
Breztri AerosphereBudesonide/Glycopyr/Formoterol1115,550$110,333
Breo ElliptaFluticasone/Vilanterol632,730$34,258

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
E1390Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rateY36310$25,058
E0431Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubingYN/R55$1,032
Q0513Pharmacy dispensing fee for inhalation drug(s); per 30 daysNN/R15$388
E1392Portable oxygen concentrator, rentalYN/R11$331
E0570Nebulizer, with compressorYN/R31$156

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.99$2,633INTUITIVE SURGICAL, INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Muhammad Imtiaz, M.D.?

Tedicare shows public-source Medicare data for Muhammad Imtiaz, M.D. (NPI 1639315435), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Muhammad Imtiaz, M.D. have ACO affiliation data?

Muhammad Imtiaz, M.D. is shown with ACO affiliation data for Keystone ACO (MSSP, ACO ID A1552) and AdvantagePoint Health Alliance - Laurel Highlands, LLC (MSSP, ACO ID A4657).

What billing organization is linked to Muhammad Imtiaz, M.D.?

Muhammad Imtiaz, M.D. is linked to SOUTHERN TIER PULMONARY & CRITICAL CARE MEDICINE LLC (billing NPI 1841303070) in the available physician profile data.

Does Muhammad Imtiaz, M.D. have Open Payments data?

Muhammad Imtiaz, M.D. has 99 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.